Life Sciences

Securing Research, Regulated Data, and Discovery

Protecting the research and systems that advance human health

Biotech firms, pharmaceutical companies, clinical research organizations, and medical device manufacturers operate at the intersection of cutting-edge science and strict regulatory expectations. ACS helps strengthen safeguards around research environments, intellectual property, and the systems that keep scientific work moving forward.

Life sciences laboratory research environment
ACS industry focus
Cybersecurity support for research and regulated data.

Built around lab systems, clinical-trial data, IP protection, 21 CFR Part 11 readiness, and research continuity.

Primary need Risk reductionWorking model Managed + advisoryStarting point Risk assessment
Focus areas

Where ACS helps life sciences teams most.

ACS helps life sciences teams protect research operations, regulated workflows, collaboration platforms, and sensitive data.

Protecting Research Data and Intellectual Property

We help strengthen access controls, monitoring, and recovery planning around laboratory environments, research repositories, and proprietary data.

FDA-Regulated Environment Readiness

ACS helps implement controls that support 21 CFR Part 11 readiness and inspection-response preparation without disrupting research workflows.

Scalable IT for Growing Life Sciences Organizations

From startup labs to clinical-stage operations, we scale your IT and security infrastructure alongside your growth.

Challenge

Why life sciences organizations face elevated technology risk.

Life sciences companies hold some of the most valuable intellectual property in the world. Years of clinical research, proprietary formulations, and unreleased trial data represent enormous competitive and financial value. Nation-state actors and organized criminal groups actively target this sector for data theft, ransomware, and industrial espionage.

01

Pharmaceutical and biotech IP is a high-value target for criminal and nation-state cyber activity

02

Clinical-trial data exposure can disrupt research timelines, sponsor reporting, and regulatory response needs

03

21 CFR Part 11 expectations raise the importance of documented audit trails and access controls for electronic records

04

Medical-device and connected research teams face growing expectations for documented controls, secure access, and supplier-risk visibility

What we deliver

Practical ACS capabilities matched to life sciences risk.

ACS connects managed IT, cybersecurity, continuity, advisory, and assessment services around the priorities that matter most for this industry.

01

Laboratory and Research Environment Security

Controlled access, network segmentation, and monitoring for lab systems, sequencing platforms, and connected research equipment.

02

21 CFR Part 11 Readiness Support

Advisory support for electronic-signature controls, audit-trail documentation, and validation-support documentation in FDA-regulated environments.

03

Clinical Trial Data Protection

Access, endpoint, email, and recovery controls for trial records, patient data, and sponsor reporting systems throughout the research lifecycle.

04

Connected Device and Lab-System Risk Readiness

Risk assessment and control-prioritization support for connected research, lab, and product-supporting environments.

05

Intellectual Property Protection

Layered controls to reduce unauthorized-access risk around formulations, research data, and proprietary processes.

06

Regulatory Evidence and Control Readiness

Ongoing assessments, evidence management, and gap prioritization so your organization is better prepared for regulatory and sponsor review.

Operational resilience

Technology support built around research continuity.

ACS helps life sciences teams align IT, cybersecurity, advisory priorities, and recovery planning around research data, regulated workflows, vendor ecosystems, and systems that support discovery.

  • 01

    Research data protection priorities

    Security guidance for sensitive research, intellectual property, collaboration spaces, and regulated workflows.

    Risk AdvisoryGRCMSSP
  • 02

    Identity and endpoint controls

    Protection for accounts, devices, email, and access paths used by research, clinical, and business teams.

    MFAEDREmail Security
  • 03

    Continuity planning for critical platforms

    Backup and recovery planning for systems supporting research operations, documentation, and collaboration.

    BC/DRBackupPlanning
  • 04

    Advisory support for regulated workflows

    Strategic IT and cyber guidance for teams navigating growth, governance, vendors, and sensitive data handling.

    vCISORisk AdvisoryGRC
Next step

Start with a focused cyber risk analysis.

We’ll help identify the most important technology and cyber-risk priorities for your organization, then map practical next steps.

Schedule a Consultation